JENNIFER HEUSINKVELT: Open Payments
NPI 1952924607 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 18 payments from 15 companies in 2025. Trend: 2023 $251 · 2024 $255 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $143 |
| Corcept Therapeutics | 2 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| PFIZER INC. | 2 | $41 |
| Astellas Pharma US Inc | 1 | $35 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| ABBVIE INC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $19 |
| Organon LLC | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
Products named: OverStitch NXT Endoscopic Suturing System, Korlym, CAPLYTA, Veozah, GARDASIL 9, QULIPTA, VYNDAMAX, Rybelsus.
Industry payments across NE — which companies pay providers there.
